Skip to main content

Table 1 Patient demographics, location, and number of sessions on AKI and ESKD patients

From: A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients

 

AKI

ESKD

Overall

 

n = 55

n = 10

n = 65

Gender

   

 Female

15 (27.3%)

4 (40.0%)

19 (29.2%)

 Male

40 (72.7%)

6 (60.0%)

46 (70.8%)

Age

n = 55

n = 10

n = 65

 

58.42 (12.71)

56.30 (8.51)

58.09 (12.13)

Weight

n = 55

n = 10

n = 65

 

75.89 (17.44)

81.60 (24.37)

76.77 (18.56)

Height

n = 45

n = 10

n = 55

 

171.52 (11.04)

168.90 (9.84)

171.05 (10.79)

Race

n = 55

n = 10

n = 65

 African

4 (7.3%)

1 (10.0%)

5 (7.7%)

 Asian

3 (5.5%)

0 (0.0%)

3 (4.6%)

 Caucasian

18 (32.7%)

5 (50.0%)

23 (35.4%)

 Hispanic

22 (40.0%)

2 (20.0%)

24 (36.9%)

Number of sessions completed

   

 1

12 (21.8%)

2 (20.0%)

14 (21.5%)

 2

8 (14.5%)

0 (0.0%)

8 (12.3%)

 3

7 (12.7%)

2 (20.0%)

9 (13.8%)

 4

4 (7.3%)

0 (0.0%)

4 (6.2%)

 5

4 (7.3%)

2 (20.0%)

6 (9.2%)

 6

20 (36.4%)

4 (40.0%)

24 (36.9%)

Hemodialysis location

   

 Floor

n = 206

n = 43

n = 249

177 (85.9%)

38 (88.4%)

215 (86.3%)

 ICU

29 (14.1%)

5 (11.6%)

34 (13.7%)

Serum albumin at dialysis initiation

n = 75

n = 23

n = 98

 

2.68 (0.35)

2.72 (0.30)

2.69 (0.34)

  1. AKI acute kidney injury, ESKD end stage kidney disease, ICU intensive care unit